Business, energy, technology, markets and global industry news from Business News Today

Align Capital Partners

PharmaDeviceNews Align Capital Partners
Representative image of point-of-care drug testing supplies in a laboratory, reflecting Premier Biotech’s NexScreen and TransMed acquisitions to expand diagnostics, e-commerce distribution and testing services.
Medical Devices & Diagnostics

Why Premier Biotech’s NexScreen and TransMed acquisitions could reshape rapid drug testing

Discover how Premier Biotech’s NexScreen and TransMed acquisitions expand point-of-care testing, e-commerce and global diagnostics reach.

Read More